China’s government fixed-income market constitutes a US $12-trillion opportunity, according to Emil Nguy.

Among the most polarizing stocks on Wall Street is one of it’s most famous — Tesla (TSLA). Since the beginning of last year, shares have climbed or dropped at least 10% more than a dozen times, as some in the investment community look at the stock as a can’t-lose, with others thinking there’s no chance the […]

In a report released today, Jason McCarthy from Maxim Group maintained a Buy rating on Moleculin Biotech (MBRX), with a price target of $3. The company’s shares opened today at $1.27. McCarthy commented: “Following last month’s clearance to begin its European clinical trial of WP1220 (STAT3 inhibitor) in the topical treatment of cutaneous T-cell lymphoma […]